drugset / Trial / NCT06390241
Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer
Phase 1
Terminated
18 enrolled
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
NaSingle-groupOpen-labelTreatment
Summary
This is an interventional, open-label, non comparative phase 2 trial enrolling patients with nonpalpable breast cancer
Timeline
- Start
- 2024-06-19
- Primary completion
- 2025-01-30
- Completion
- 2025-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 90Y DOTA-biotin | Unknown | 28 mbq | Other |
| Subject | 90Y DOTA-biotin | Unknown | 57 mbq | Other |
| Subject | 90Y DOTA-biotin | Unknown | 126 mbq | Other |
| Subject | Avidin | Unknown | 6 mg | Other |
| Subject | Avidin | Unknown | 10 mg | Other |